It shares the same active ingredient, semaglutide, as Wegovy and Rybelsus
Human trials are ongoing, but even modest effects in opioid use disorder could be clinically meaningful given the favorable safety profile of GLP-1 drugs compared with existing treatments
So, what are our options for surviving
A comprehensive plan includes nutritional counseling, regular monitoring, and ongoing support
GLP-1 medications cause nausea, vomiting, diarrhea, and constipation in a substantial percentage of patients, especially during dose titration
This nutraceutical supplement is intended for adults seeking antioxidant support and improved overall well-being